Journal article
Randomized controlled trials and neuro-oncology: should alternative designs be considered?
Abstract
Deficiencies in design and reporting of randomized controlled trials (RCTs) hinders interpretability and critical appraisal. The reporting quality of recent RCTs in neuro-oncology was analyzed to assess adequacy of design and reporting. The MEDLINE and EMBASE databases were searched to identify non-surgical RCTs (years 2005–2014, inclusive). The CONSORT and Jadad scales were used to assess the quality of design/reporting. Studies published in …
Authors
Mansouri A; Shin S; Cooper B; Srivastava A; Bhandari M; Kondziolka D
Journal
Journal of Neuro-Oncology, Vol. 124, No. 3, pp. 345–356
Publisher
Springer Nature
Publication Date
9 2015
DOI
10.1007/s11060-015-1870-6
ISSN
0167-594X